Beijing, China

Fengjuan Li


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):

Title: Innovations of Fengjuan Li in Cardiovascular Disease Detection

Introduction

Fengjuan Li is a notable inventor based in Beijing, China. He has made significant contributions to the field of genetic engineering, particularly in the detection of soluble ST2 protein, which is crucial for diagnosing cardiovascular diseases. His innovative work has led to the development of a unique nucleic acid aptamer that specifically recognizes this protein.

Latest Patents

Fengjuan Li holds a patent titled "Aptamer for specifically recognizing soluble ST2 protein and application of the same." This patent addresses the technical challenge of specifically detecting sST2 protein. The invention utilizes nucleic acid aptamers of single-stranded DNA with specific nucleotide sequences, as detailed in SEQ ID No. 1-10. By employing SELEX technology, combined with high-throughput sequencing and bioinformatics analysis, he has successfully reduced the rounds of screening to identify candidate nucleic acid aptamers. The resulting aptamer exhibits high specificity, stability, and ease of synthesis, making it suitable for applications in biosensors and the diagnosis of cardiovascular diseases.

Career Highlights

Fengjuan Li is affiliated with the Beijing Institute of Heart, Lung & Blood Vessel Diseases. His work at this institution has been pivotal in advancing research related to cardiovascular health. He has demonstrated a commitment to innovation and excellence in his field, contributing to the understanding and detection of critical biomarkers.

Collaborations

Fengjuan Li has collaborated with esteemed colleagues such as Jie Du and Yuan Wang. These partnerships have further enriched his research and have contributed to the successful development of his patented technologies.

Conclusion

Fengjuan Li's innovative contributions to the detection of soluble ST2 protein exemplify the intersection of genetic engineering and medical diagnostics. His work not only enhances our understanding of cardiovascular diseases but also paves the way for future advancements in this critical area of health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…